Drug
Elbasvir
Elbasvir: highest development phase Post-Market, developed by Merck. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| elbasvir, grazoprevir NCT03022006 | Post-Market | Chronic Hepatitis C |
Latest
No recent events.
Follow Elbasvir on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.